Telesis Bio, Inc.
Subcutaneous Delivery of Messenger RNA
Last updated:
Abstract:
The present invention provides, among other things, methods of formulating nucleic acid-containing nanoparticles with an mRNA encoding an enzyme to afford efficient delivery of payload to a cell or tissue of interest via subcutaneous administration. The resulting payload can be efficiently delivered to the liver and other organs or tissues of a treated subject.
Status:
Application
Type:
Utility
Filling date:
14 May 2019
Issue date:
22 Jul 2021